2673-4389

Livers

MDPI AG

Health Score

0 Excellent

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 17 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact17 DOIs
2

Deposit reference lists for 3 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact3 DOIs

DOIs for this ISSN

Showing the top 5 of 288 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Perfluoroalkyl Carboxylic Acids Interact with the Human Bile… (10.3390/livers1040017)
ORCID
38.91 35
2 Principles of Nutritional Management in Patients with Liver… (10.3390/livers3020013)
ORCID
28.65 13
3 Applicability of Statins in Metabolic Dysfunction-Associated… (10.3390/livers5010004)
ORCID
26.03 10
4 Artificial Intelligence, Machine Learning, and Deep Learning… (10.3390/livers4010004)
ORCID
25.00 9
5 Liver Toxicity Induced by Exposure to Bisphenol Analogs at E… (10.3390/livers5020024)
ORCID
22.58 7
6 Anti-Metastatic Activity of Tagitinin C from Tithonia divers… (10.3390/livers2040030)
ORCID
21.13 6
7 Understanding the SARS-CoV-2–Human Liver Interactome Using a… (10.3390/livers4020016)
ORCID
17.47 4
8 Hepatotoxicity of Herbal and Dietary Supplements a Review of… (10.3390/livers5030042)
ORCID
15.05 3
9 Serendipity in Medicine-Elevated Immunoglobulin E Levels Ass… (10.3390/livers4020012)
ORCID
7.53 1
10 Progressive Metabolic Dysfunction-Associated Steatotic Liver… (10.3390/livers4040047)
ORCID
7.53 1
11 Effects of SARS-CoV-2 Spike S1 Subunit on the Interplay Betw… (10.3390/livers5010001)
ORCID
7.53 1
12 Livers: A New Open Access Forum for Liver Research (10.3390/livers1010001)
References
0.00 0
13 The Space of Disse: The Liver Hub in Health and Disease (10.3390/livers1010002)
0.00 45
14 Effects of Ethanol Feeding in Early-Stage NAFLD Mice Induced… (10.3390/livers1010003)
0.00 0
15 How Diet-Induced Changes in the “Gut-Liver” Axis Affect Chro… (10.3390/livers1010004)
0.00 3
16 The Threat of Multiple Liver Carcinogens in the Population o… (10.3390/livers1010005)
0.00 3
17 Mac-2 Binding Protein Glycosylation Isomer for Screening Hig… (10.3390/livers1020006)
0.00 2
18 The Impact of the NLRP3 Pathway in the Pathogenesis of Non-A… (10.3390/livers1020007)
0.00 6
19 PDK2: An Underappreciated Regulator of Liver Metabolism (10.3390/livers1020008)
0.00 3
20 The Cape Gooseberry Constituent Physalin B Ameliorates Nonal… (10.3390/livers1020009)
0.00 0
21 Mitochondrial Dynamics in Drug-Induced Liver Injury (10.3390/livers1030010)
0.00 28
22 The COP9 Signalosome Variant CSNCSN7A Stabilizes the Deubiqu… (10.3390/livers1030011)
0.00 4
23 Congenital Hepatic Fibrosis as a Cause of Recurrent Cholangi… (10.3390/livers1030012)
0.00 4
24 Assisting Difficult Liver Operations Using 3D Printed Models (10.3390/livers1030013)
0.00 6
25 Targeting Gut–Liver Axis for Treatment of Liver Fibrosis and… (10.3390/livers1030014)
0.00 12
26 Wnt Signaling Pathway Is among the Drivers of Liver Metastas… (10.3390/livers1040015)
0.00 6
27 Changes in PGC-1α-Dependent Mitochondrial Biogenesis Are Ass… (10.3390/livers1040016)
0.00 3
28 Prevalence of Hepatitis B Serum Markers in Young Military Re… (10.3390/livers1040018)
0.00 0
29 Na+-Taurocholate Co-Transporting Polypeptide (NTCP) in Liver… (10.3390/livers1040019)
0.00 5
30 Fructose Consumption and Hepatocellular Carcinoma Promotion (10.3390/livers1040020)
0.00 6
31 Noncoding RNAs Interactions in Hepatic Stellate Cells during… (10.3390/livers1040021)
0.00 6
32 Redrawing the Map to Novel DILI Biomarkers in Circulation: W… (10.3390/livers1040022)
0.00 17
33 Statistical Machine Learning Approaches to Liver Disease Pre… (10.3390/livers1040023)
0.00 57
34 Predictive Factors for Hepatocellular Carcinoma Development… (10.3390/livers1040024)
0.00 6
35 Biliary hCGβ Is a Potential Novel Marker for Prediction of B… (10.3390/livers1040025)
0.00 2
36 Cellular and Molecular Mechanisms Underlying Scope and Limit… (10.3390/livers2010001)
0.00 0
37 TAM Receptors in the Pathophysiology of Liver Disease (10.3390/livers2010002)
0.00 6
38 Oxidative Stress in Non-Alcoholic Fatty Liver Disease (10.3390/livers2010003)
0.00 76
39 Acknowledgment to Reviewers of Livers in 2021 (10.3390/livers2010004)
References ORCID
0.00 0
40 Anti-Inflammatory Dietary Approach to Prevent the Developmen… (10.3390/livers2010005)
0.00 1
41 A Comprehensive Review on the Risk of Metabolic Syndrome and… (10.3390/livers2020006)
0.00 10
42 A Call for Implementation of an Evidence-Based, Quality Impr… (10.3390/livers2020007)
0.00 2
43 Acetaminophen Hepatotoxicity: Not as Simple as One Might Thi… (10.3390/livers2030008)
0.00 5
44 Seroprevalence of Hepatitis E Virus Antibodies (IgG) in the… (10.3390/livers2030009)
0.00 16
45 Inflammaging, a Common Factor in the Development of Sarcopen… (10.3390/livers2030010)
0.00 2
46 A Comprehensive Review on the Use of Herbal Dietary Suppleme… (10.3390/livers2030011)
0.00 14
47 Therapeutic Potential of Human Microbiome-Based Short-Chain… (10.3390/livers2030012)
0.00 11
48 Preventive Effect of Gamma-Oryzanol on Physiopathological Pr… (10.3390/livers2030013)
0.00 10
49 Protein Catabolism and the Dysregulation of Energy Intake-Re… (10.3390/livers2030014)
0.00 6
50 Established Liver Cell Lines: Are You Sure to Have the Right… (10.3390/livers2030015)
0.00 11